Navigation Links
Cardium's InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
Date:3/19/2008

clearance for use in inducing, maintaining and reversing mild hypothermia in neurosurgical patients, both in surgery and in recovery or intensive care. The system has also received FDA clearance for use in cardiac patients in order to achieve or maintain normal body temperatures during surgery and in recovery / intensive care, and as an adjunctive treatment for fever control in patients with cerebral infarction and intracerebral hemorrhage. Potential additional applications of the technology include endovascular cooling for cardiac arrest, acute ischemic stroke and myocardial infarction (heart attack). InnerCool's next-generation RapidBlue(TM) system for high-performance endovascular temperature modulation is expected to receive FDA clearance in the second quarter 2008, and to initially have the same clearance as the Celsius Control System. The RapidBlue system includes a programmable console with an enhanced user interface and a catheter designed to quickly modulate patient temperature in association with surgery or other medical procedures. The RapidBlue system powers InnerCool's Accutrol(TM) catheter, which has a flexible metallic temperature control element and a built-in temperature feedback sensor to provide fast and precise patient temperature control.

About Cardium

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications. Cardium's lead product candidate, Generx(TM) (alferminogene tadenovec, Ad5FGF4), is a DNA-based growth factor therapeutic being developed for potential use by interventional cardiologists as a one-time treatment to promote and stimulate the growth of collateral circulation in the hearts of patients with ischemic conditions such as recurrent angina. For more information about Cardium and it
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Current and Emerging Therapies Have No Advantage Over Pfizers Lyrica in Their Effect on Patients Quality of Life in the Treatment of Diabetic Neuropathy
2. Newly Labeled Therapies for Neuropathic Pain, Including Drugs From Pfizer and Eli Lilly, Will Drive Growth in the Chronic Pain Drug Market
3. New study of targeted therapies for breast cancer -- model for global clinical trials
4. FSU College of Medicine researcher seeks to uncover new cancer therapies
5. New Stroke Therapies Show Promise
6. Aegis Therapies and Rocky Mountain University of Health Professions Announce Scholarship Recipients
7. Tailoring glioblastoma therapies: 1 size does not fit all
8. Integrated Laser Therapies Launches, Offers Low-power, Therapeutic Laser Devices and Training for Therapists and Consumers
9. Presidents Proposed 2009 Medicare Budget Would Weaken Seniors Access to Durable Medical Equipment and Therapies Required in the Home
10. New Therapies Could Change Organ Transplants
11. Pipeline for New Obesity Therapies is Focus of New Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 (HealthDay News) -- Children who have emergency ... complications and potentially even death than those who ... However, the Johns Hopkins researchers noted that ... researchers analyzed data on nearly 440,000 simple emergency ... over a 22-year period. The surgeries are ...
(Date:7/11/2014)... According to a new market research report “Internet ... (ZigBee, Z-Wave, Bluetooth, Wi-Fi, NFC, RFID), Application Vertical (Building ... & Geography - Global Trends & Forecasts to 2014 ... was worth $1029.5 Billion in 2013, and is expected ... CAGR of 4.08% from 2014 to 2020. , ...
(Date:7/11/2014)... The Miriam Hospital have found that people with ... rates of smoking than those without mobility impairments. ... to attempt quitting than those without mobility impairments, ... for this population. The study and its findings ... the American Journal of Public Health . ...
(Date:7/11/2014)... HealthDay Reporter THURSDAY, July 10, 2014 (HealthDay ... worldwide scourge of dengue fever was somewhat successful in a ... dengue fever in 56 percent of the 10,000 kids who ... than 88 percent of them from severe disease. In the ... death. "This vaccine has already proven to be safe," ...
(Date:7/11/2014)... 2014 Last month Watkins Insurance Group ... joins the agency as a specialist in insurance and ... a Bachelor’s Degree in Business Administration from Texas State ... will manage everything from performance and payment bonds, license ... specialized needs for those in the asphalt supplier industry. ...
Breaking Medicine News(10 mins):Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Miriam Hospital study examines smoking prevalence 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3
... 3 The following is being issued by The American ... by federally funded organizations operating in every state has had ... during a period when hospital performance improved faster than outpatient ... The annual National Healthcare Quality Report, just released by the ...
... treatment or not, study finds , WEDNESDAY, June 3 ... before a mammogram doesn,t lower the likelihood of being ... than 1,700 women aged 45 to 80 has found. ... women,s breasts -- and make mammograms harder to read," ...
... PLYMOUTH MEETING, Pa., June 3 /PRNewswire-Asia-FirstCall/ -- ... or the "Company") today announced,that it will be featured ... conference call series to discuss the impact of,China Healthcare ... will be hosted by Ding Ding, Ph.D., SIG,s senior ...
... , -- Record non-infant formula nutritional sales of $9.8 million ... Earnings per share of $0.33, an increase of 20% over last ... million (Year-to-date operating cash flow of $26 million) , -- Full ... pre-tax earnings growth of 10% to 15% over fiscal 2008 ...
... IMAGINE Software, a leading provider of ... within the IMAGINEradiology(TM) practice management system at IMAGINE,s 2009 ... , , The system received a number ... deployment and maintenance distribution through application virtualization; "I-Connect," ...
... of Obama and His Agenda; Jon Stewart Bests Stephen Colbert, ... 3 Progressives gathered at this week,s "America,s Future Now" ... ,s first 100 days, but they are very focused on ... straw poll of participants conducted by Greenberg Quinlan Rosner Research ...
Cached Medicine News:Health News:QIO Support Accelerates Hospital Improvement in Heart Care, Researchers Find 2Health News:Pausing Hormone Therapy Doesn't Cut Mammogram Recalls 2Health News:BMP Sunstone to be Featured on SIG's 'China Healthcare On Call' Conference Call Series 2Health News:Martek Announces Second Quarter 2009 Financial Results 2Health News:Martek Announces Second Quarter 2009 Financial Results 3Health News:Martek Announces Second Quarter 2009 Financial Results 4Health News:Martek Announces Second Quarter 2009 Financial Results 5Health News:Martek Announces Second Quarter 2009 Financial Results 6Health News:Martek Announces Second Quarter 2009 Financial Results 7Health News:Martek Announces Second Quarter 2009 Financial Results 8Health News:Martek Announces Second Quarter 2009 Financial Results 9Health News:Martek Announces Second Quarter 2009 Financial Results 10Health News:Martek Announces Second Quarter 2009 Financial Results 11Health News:Martek Announces Second Quarter 2009 Financial Results 12Health News:IMAGINE Software Unveils Advanced IMAGINEradiology(TM) Features 2Health News:'America's Future Now' Straw Poll: Progressives See Health Care Reform With Public Option As Top Priority 2
(Date:7/11/2014)... 2014 According to a new ... Market (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - ... 2013-2019" the global endoscopy devices market was valued at ... grow at a CAGR of 6.8% from 2013 to ... billion in 2019. Browse the full Endoscopy ...
(Date:7/10/2014)... India , July 11, 2014  Major ... treatment of cancer are being highlighted in a ... Mumbai from 10-12 July, 2014.  Renowned national ... to share best practices and exchange knowledge on ... precise, accurate and efficient. The ...
(Date:7/10/2014)...  RESMED INC. (NYSE: RMD ) today announced ... ended June 30, 2014 results on Thursday, July 31, 2014, ... release with ResMed,s results will be issued after 1:00 p.m. ... to discuss operating results and future outlook. The ... Pacific Time and the live webcast of the call can ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2
... Soligenix, Inc. (OTC Bulletin Board: SNGX ) ... today that it has appointed Kevin Horgan, MD, as ... Horgan is a board-certified gastroenterologist with a research background ... patients with inflammatory bowel disease, including graft-versus-host disease (GVHD). ...
... JOLLA, Calif., Feb. 1, 2011 Transdel Pharmaceuticals, ... a specialty pharmaceutical company focused on developing topically ... announced that the Company has been exploring strategic alternatives ... American MedTech Advisors and ESC Advisors, a division ...
Cached Medicine Technology:Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer 2Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer 3Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer 4Transdel Pharmaceuticals Announces Exploration of Strategic Alternatives 2Transdel Pharmaceuticals Announces Exploration of Strategic Alternatives 3
... operating lamp offers a light output of ... field diameter. The innovative lamp also produces ... additional advantage of the fascinating gas discharge ... is top technology, setting new standards with ...
The Next Generation in Single Lamp Technology, Advanced Optics & Reflector Design, Extended Depth of Field, 54" Useable Column of Light, High Intensity, Cool Beam Temperature...
... an interventional guidance device that uses ... the accuracy of computed tomography (CT)-guided ... accuracy, SimpliCT® also has the potential ... puncture procedures including biopsies and fluid ...
Up-tapered output compresses NA to give low NA fiber performance on high NA fiber stock....
Medicine Products: